Bourne Lent Asset Management’s St Jude Medical STJ Stock Holding History

Bourne Lent Asset Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,550	Closed	-$285K	–	62
2016 Q4	$285K	Sell	3,550 -900	-20%	-$71.4K	0.17%	51
2016 Q3	$355K	Hold	4,450	–	–	0.26%	39
2016 Q2	$347K	Hold	4,450	–	–	0.27%	43
2016 Q1	$245K	Hold	4,450	–	–	0.2%	47
2015 Q4	$275K	Hold	4,450	–	–	0.21%	46
2015 Q3	$281K	Hold	4,450	–	–	0.23%	43
2015 Q2	$325K	Hold	4,450	–	–	0.26%	41
2015 Q1	$291K	Buy	+4,450	New	+$296K	0.22%	45

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Bourne Lent Asset Management's STJ Position: Q1 2017 in Review

Bourne Lent Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,550 shares — an estimated $285K sold.

Bourne Lent Asset Management first reported a position in STJ in Q1 2015 and held it in 8 quarters. The position peaked at $355K in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Bourne Lent Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Bourne Lent Asset Management sold 3,550 St Jude Medical shares in Q1 2017, an estimated $285K.
Bourne Lent Asset Management first reported a position in St Jude Medical in Q1 2015 and held it in 8 quarters.
Bourne Lent Asset Management's St Jude Medical position peaked at $355K in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bourne Lent Asset Management's 13F filing for Q1 2017, filed 27 Apr 2017.